US Patent 8101743 Modulation of transthyretin expression
Patent 8101743 was granted and assigned to Ionis Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8101743 Modulation of transthyretin expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.